Last reviewed · How we verify
Emecort (fluprednidene acetate)
Emecort (generic name: fluprednidene acetate) is a fluprednidene acetate drug. It is currently in unknown development.
Emecort works by binding to glucocorticoid receptors in the body, triggering a cascade of anti-inflammatory effects.
Emecort, also known as fluprednidene acetate, is a synthetic corticosteroid medication. It is a small molecule that works by mimicking the effects of cortisol in the body, reducing inflammation and suppressing the immune system. Emecort is used to treat various inflammatory conditions, but its specific indications are not well-documented. The commercial status of Emecort is unclear, and it may be patented or available as a generic medication. As a corticosteroid, Emecort carries key safety considerations, including potential side effects such as adrenal suppression and increased risk of infections.
At a glance
| Generic name | fluprednidene acetate |
|---|---|
| Drug class | fluprednidene acetate |
| Therapeutic area | Immunology |
| Phase | unknown |
Mechanism of action
Imagine your body's immune system as a fire alarm that sounds when it detects an intruder. Emecort is like a fire alarm silencer that reduces the alarm's sensitivity, allowing the body to calm down and reduce inflammation. This helps to alleviate symptoms of conditions like arthritis or asthma.
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Emecort CI brief — competitive landscape report
- Emecort updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Emecort
What is Emecort?
How does Emecort work?
What is the generic name of Emecort?
What drug class is Emecort in?
What development phase is Emecort in?
Related
- Drug class: All fluprednidene acetate drugs
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Immunology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing